Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone
By BSK

Free Abstracts

  Autoimmune Disorders

  Free Subscription


Articles published in Lancet

Retrieve available abstracts of 55 articles:
HTML format
Text format



Single Articles


    March 2017
  1. WYATT RJ
    Are we ready for targeted therapy for IgA nephropathy?
    Lancet. 2017 Mar 28. pii: S0140-6736(17)30820.
    PubMed     Text format    


  2. FELLSTROM BC, Barratt J, Cook H, Coppo R, et al
    Targeted-release budesonide versus placebo in patients with IgA nephropathy (NEFIGAN): a double-blind, randomised, placebo-controlled phase 2b trial.
    Lancet. 2017 Mar 28. pii: S0140-6736(17)30550.
    PubMed     Text format     Abstract available


  3. ATKINS H, Freedman MS
    Immunoablation and aHSCT for aggressive multiple sclerosis - Authors' reply.
    Lancet. 2017;389:908.
    PubMed     Text format    


  4. HARRIS M, Cossburn M, Gregory R
    Immunoablation and aHSCT for aggressive multiple sclerosis.
    Lancet. 2017;389:907-908.
    PubMed     Text format    


    January 2017
  5. BUENZ EJ, Parry GJ, Ranta A
    Guillain-Barre syndrome: surveillance and cost of treatment strategies.
    Lancet. 2017;389:253.
    PubMed     Text format    


  6. WILLISON HJ, Jacobs BC, van Doorn PA
    Guillain-Barre syndrome: surveillance and cost of treatment strategies - Authors' reply.
    Lancet. 2017;389:253-254.
    PubMed     Text format    


  7. DURRHEIM DN
    Guillain-Barre syndrome: surveillance and cost of treatment strategies.
    Lancet. 2017;389:252-253.
    PubMed     Text format    


  8. CHEN H, Kwong JC, Copes R, Tu K, et al
    Living near major roads and the incidence of dementia, Parkinson's disease, and multiple sclerosis: a population-based cohort study.
    Lancet. 2017 Jan 4. pii: S0140-6736(16)32399.
    PubMed     Text format     Abstract available


    November 2016
  9. COMI G, Radaelli M, Soelberg Sorensen P
    Evolving concepts in the treatment of relapsing multiple sclerosis.
    Lancet. 2016 Nov 23. pii: S0140-6736(16)32388.
    PubMed     Text format     Abstract available


  10. ONTANEDA D, Thompson AJ, Fox RJ, Cohen JA, et al
    Progressive multiple sclerosis: prospects for disease therapy, repair, and restoration of function.
    Lancet. 2016 Nov 23. pii: S0140-6736(16)31320.
    PubMed     Text format     Abstract available


  11. BROWNLEE WJ, Hardy TA, Fazekas F, Miller DH, et al
    Diagnosis of multiple sclerosis: progress and challenges.
    Lancet. 2016 Nov 23. pii: S0140-6736(16)30959.
    PubMed     Text format     Abstract available


    September 2016
  12. BOLINDER J, Antuna R, Geelhoed-Duijvestijn P, Kroger J, et al
    Novel glucose-sensing technology and hypoglycaemia in type 1 diabetes: a multicentre, non-masked, randomised controlled trial.
    Lancet. 2016 Sep 9. pii: S0140-6736(16)31535.
    PubMed     Text format     Abstract available


    July 2016
  13. LAZARUS C, Guichard M, Philippe JM, Paux T, et al
    The French experience of the threat posed by Zika virus.
    Lancet. 2016;388:9-11.
    PubMed     Text format    


  14. TARANTINO MD, Bussel JB, Blanchette VS, Despotovic J, et al
    Romiplostim in children with immune thrombocytopenia: a phase 3, randomised, double-blind, placebo-controlled study.
    Lancet. 2016;388:45-54.
    PubMed     Text format     Abstract available


  15. CHATURVEDI S, McCrae KR
    Treatment of chronic immune thrombocytopenia in children with romiplostim.
    Lancet. 2016;388:4-6.
    PubMed     Text format    


    June 2016
  16. FONTANET A, Cao-Lormeau VM, Dub T, Mallet HP, et al
    Association between Guillain-Barre syndrome and Zika virus infection - Authors' reply.
    Lancet. 2016;387:2600.
    PubMed     Text format    


  17. BAUTISTA LE, Sethi AK
    Association between Guillain-Barre syndrome and Zika virus infection.
    Lancet. 2016;387:2599-600.
    PubMed     Text format    


  18. AVELINO-SILVA VI, Martin JN
    Association between Guillain-Barre syndrome and Zika virus infection.
    Lancet. 2016;387:2599.
    PubMed     Text format    


  19. RUPERTO N, Pistorio A, Ravelli A, Angioloni S, et al
    The PRINTO juvenile dermatomyositis trial - Authors' reply.
    Lancet. 2016;387:2601.
    PubMed     Text format    


  20. DALE A, Milosevic I, Goldacre B
    The PRINTO juvenile dermatomyositis trial.
    Lancet. 2016;387:2600-1.
    PubMed     Text format    


  21. ATKINS HL, Bowman M, Allan D, Anstee G, et al
    Immunoablation and autologous haemopoietic stem-cell transplantation for aggressive multiple sclerosis: a multicentre single-group phase 2 trial.
    Lancet. 2016 Jun 8. pii: S0140-6736(16)30169.
    PubMed     Text format     Abstract available


  22. DORR J
    Haemopoietic stem-cell transplantation for multiple sclerosis: what next?
    Lancet. 2016 Jun 8. pii: S0140-6736(16)30377.
    PubMed     Text format    


  23. ZOMA AA
    Clinical overlap in proximal artery stenosis: two disorders or one?
    Lancet. 2016;387:2350.
    PubMed     Text format    


  24. JAIN P, Ruchin P, Suttie J
    Proximal pulmonary artery stenosis: a rare manifestation of granulomatosis with polyangiitis.
    Lancet. 2016;387:2349-50.
    PubMed     Text format    


  25. REWERS M, Ludvigsson J
    Environmental risk factors for type 1 diabetes.
    Lancet. 2016;387:2340-8.
    PubMed     Text format     Abstract available


  26. POCIOT F, Lernmark A
    Genetic risk factors for type 1 diabetes.
    Lancet. 2016;387:2331-9.
    PubMed     Text format     Abstract available


  27. RUBIN R
    Kevan Herold: untangling type 1 diabetes in the clinic and the lab.
    Lancet. 2016;387:2283.
    PubMed     Text format    


  28. RUBIN R
    Profile: Type 1 Diabetes TrialNet.
    Lancet. 2016;387:2280.
    PubMed     Text format    



  29. Towards a better understanding of type 1 diabetes.
    Lancet. 2016;387:2264.
    PubMed     Text format    


    May 2016
  30. FLOEGE J, Amann K
    Primary glomerulonephritides.
    Lancet. 2016;387:2036-48.
    PubMed     Text format     Abstract available


  31. GUILLEVIN L, Regent A
    Treating giant-cell arteritis: is IL-6 the cytokine to target?
    Lancet. 2016;387:1882-1883.
    PubMed     Text format    


    April 2016
  32. BARNETT R
    Systemic lupus erythematosus.
    Lancet. 2016;387:1711.
    PubMed     Text format    


  33. BRASIL P, Sequeira PC, Freitas AD, Zogbi HE, et al
    Guillain-Barre syndrome associated with Zika virus infection.
    Lancet. 2016;387:1482.
    PubMed     Text format    


  34. SNYDER A
    John Kurtzke.
    Lancet. 2016;387:1370.
    PubMed     Text format    


    March 2016
  35. DE LEO S, Lee SY, Braverman LE
    Hyperthyroidism.
    Lancet. 2016 Mar 30. pii: S0140-6736(16)00278.
    PubMed     Text format     Abstract available


  36. VILLIGER PM, Adler S, Kuchen S, Wermelinger F, et al
    Tocilizumab for induction and maintenance of remission in giant cell arteritis: a phase 2, randomised, double-blind, placebo-controlled trial.
    Lancet. 2016 Mar 4. pii: S0140-6736(16)00560.
    PubMed     Text format     Abstract available


  37. MECHARLES S, Herrmann C, Poullain P, Tran TH, et al
    Acute myelitis due to Zika virus infection.
    Lancet. 2016 Mar 3. pii: S0140-6736(16)00644.
    PubMed     Text format    


    February 2016
  38. WILLISON HJ, Jacobs BC, van Doorn PA
    Guillain-Barre syndrome.
    Lancet. 2016 Feb 29. pii: S0140-6736(16)00339.
    PubMed     Text format     Abstract available


  39. CAO-LORMEAU VM, Blake A, Mons S, Lastere S, et al
    Guillain-Barre Syndrome outbreak associated with Zika virus infection in French Polynesia: a case-control study.
    Lancet. 2016 Feb 29. pii: S0140-6736(16)00562.
    PubMed     Text format     Abstract available


  40. SMITH DW, Mackenzie J
    Zika virus and Guillain-Barre syndrome: another viral cause to add to the list.
    Lancet. 2016 Feb 29. pii: S0140-6736(16)00564.
    PubMed     Text format    


  41. SARGENT J
    Rheumatology--a call for papers.
    Lancet. 2016;387:519.
    PubMed     Text format    


    January 2016
  42. SEGAL BM, Stuve O
    Primary progressive multiple sclerosis-why we are failing.
    Lancet. 2016 Jan 27. pii: S0140-6736(16)00158.
    PubMed     Text format    


  43. LUBLIN F, Miller DH, Freedman MS, Cree BA, et al
    Oral fingolimod in primary progressive multiple sclerosis (INFORMS): a phase 3, randomised, double-blind, placebo-controlled trial.
    Lancet. 2016 Jan 27. pii: S0140-6736(15)01314.
    PubMed     Text format     Abstract available


  44. MILOSEVIC I, Slade E, Drysdale H
    Eltrombopag for chronic immune thrombocytopenia.
    Lancet. 2016;387:336.
    PubMed     Text format    


  45. GRAINGER JD
    Eltrombopag for chronic immune thrombocytopenia - Authors' reply.
    Lancet. 2016;387:336-7.
    PubMed     Text format    


    December 2015
  46. FEEHALLY J
    Glomerulonephritis from a chronically infected implanted device.
    Lancet. 2015;386:2364.
    PubMed     Text format    


  47. SARITAS T, Brandenburg V, Federico G, Grone HJ, et al
    Glomerulonephritis triggered by a chronically infected left ventricular assist device.
    Lancet. 2015;386:2363-4.
    PubMed     Text format    


    November 2015
  48. MIOSSEC P
    Progress in the treatment of juvenile dermatomyositis.
    Lancet. 2015 Nov 27. pii: S0140-6736(15)01023.
    PubMed     Text format    


  49. RUPERTO N, Pistorio A, Oliveira S, Zulian F, et al
    Prednisone versus prednisone plus ciclosporin versus prednisone plus methotrexate in new-onset juvenile dermatomyositis: a randomised trial.
    Lancet. 2015 Nov 27. pii: S0140-6736(15)01021.
    PubMed     Text format     Abstract available


  50. DHALIWAL HS, Sekhon GS, Rai N, Nampoothiri RV, et al
    An unusual medical cause of abdominal pain diagnosed by urological abnormalities.
    Lancet. 2015 Nov 13. pii: S0140-6736(15)00806.
    PubMed     Text format    


  51. LOCKWOOD DN, Lambert SM, Walker SL
    Cutaneous nodules with positive autoantibodies: diagnostic pitfalls.
    Lancet. 2015;386:1916.
    PubMed     Text format    


  52. ZHANG G, Jin H, Chen H, Lu Q, et al
    Cutaneous nodules with positive autoantibodies: histoid leprosy.
    Lancet. 2015;386:1915-6.
    PubMed     Text format    


    October 2015
  53. KIPFER S, Frigerio S, Hench J, Aussy A, et al
    Immune-mediated necrotising myopathy linked to statin use.
    Lancet. 2015;386:e26.
    PubMed     Text format    


  54. NEUNERT CE, Grace RF
    Thrombopoietin-receptor agonists in children with immune thrombocytopenia.
    Lancet. 2015;386:1606-9.
    PubMed     Text format    


  55. GRAINGER JD, Locatelli F, Chotsampancharoen T, Donyush E, et al
    Eltrombopag for children with chronic immune thrombocytopenia (PETIT2): a randomised, multicentre, placebo-controlled trial.
    Lancet. 2015;386:1649-58.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Autoimmune Disorders is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: